Effect of non-absorbable antibiotic, rifaximin in patients with irritable bowel syndrome: A single-center randomized controlled study
Journal Title: National Journal of Physiology, Pharmacy and Pharmacology - Year 2018, Vol 8, Issue 6
Abstract
Background: Irritable bowel syndrome (IBS), most common functional bowel disease, does not have a definite treatment. Studies revealed the involvement of bacterial overgrowth for its pathology. The aim of this study is to evaluate the effect of a non-absorbable antibiotic. Aims and Objectives: The primary objective of the study is to assess the efficacy of a 14 days course of oral rifaximin at 400 mg thrice daily in patients with IBS without constipation. The secondary objective of this study is to evaluate the safety of a 14 days course of rifaximin at 400 mg thrice daily as compared with placebo in patients with IBS without constipation. Materials and Methods: In this single-center, randomized, placebo-controlled study, we recruited patients, using Rome III criteria in 2 years. Treatment group received rifaximin 400 mg thrice daily for 2 weeks. All patients underwent symptom assessment and safety assessment before inclusion, at the end of the treatment and 1 week after the regimen. Primary endpoint (proportion of patients who achieved adequate relief of IBS symptoms) and Likert scales of symptoms of both groups were compared. Results: Proportion of subject, who achieved adequate relief of IBS symptoms in the rifaximin arm, is more than placebo (68% vs. 39.1%). At the end of 2 weeks therapy, both groups show significant improvement in bloating score (P < 0.002), pain score (P < 0.001), and overall score (P < 0.002) and it continued for 1 more week. There were no significant adverse effects reported. Conclusion: A 2 weeks course of 400 mg rifaximin thrice daily regimen provided a significant improvement in global IBS symptoms.
Authors and Affiliations
Bhagyalekshmi N, Ramesh M, Prathibha V K, Xavier Ignatius J
Keywords
Related Articles
- EP ID EP490385
- DOI 10.5455/njppp.2018.8.1246807022018
- Views 116
- Downloads 0
The effect of fexofenadine, a newer second-generation antihistaminic, on phenobarbitone sleeping time and its comparison with terfenadine, astemizole and cetirizine in albino rats
Background: The second-generation antihistaminic fexofenadine has been claimed to be superior to terfenadine and cetirizine, in possessing the negligible sedating property and can be safely given to pilots and drivers. H...
Mothers’ knowledge, attitudes, and performance toward household accidents at home in children 1–5 years old: An intervention study
Background: Household accidents are the main cause of mortality among children under 6 years. In many cases, these accidents lead to permanent disability and death in children. Aims and Objectives: This study aimed to co...
Comparative analysis of choice reaction times with randomly variable foreperiods in normal individuals and schizophrenic patients
Background: Reaction time (RT) is an index of brain’s biological efficiency. RT can indicate sensorimotor variability with varying foreperiods (FPs) and can indicate mental dysfunction like schizophrenia. Aims and Object...
“TRAIT” level of perceived anxiety and effect of instrumental background music after induced stress test on “STATE” level of perceived anxiety in students from different ethnic groups - A randomized control trial
Background: Stress in medical students is well known, but ethnic variations in general-anxiety levels and effect of instrumental music, in relation to stress test, on anxiety in these ethnicities remain obscure. Aims and...
Comparative evaluation of atorvastatin and simvastatin on critical fusion frequency in healthy volunteers
Background: Atorvastatin and simvastatin are the most frequently prescribed among statins to reduce high lipid levels. Statins are reported to alter cognitive functions. However, the results are equivocal as numbers of s...